Top 5 Drug Type | Count |
---|---|
Small molecule drug | 9 |
Monoclonal antibody | 1 |
Target |
Mechanism VDR agonists |
Active Org. |
Originator Org.- |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date01 Jan 1993 |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date04 Oct 1991 |
Target |
Mechanism GR agonists |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date15 Jun 1982 |
Start Date25 Jan 2024 |
Sponsor / Collaborator |
Start Date21 Jun 2023 |
Sponsor / Collaborator |
Start Date31 May 2023 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Tacalcitol Hydrate ( VDR ) | Pityriasis More | Approved |
Ketoconazole ( C14DM ) | Tinea corporis More | Approved |
Betamethasone Valerate/Gentamicin Sulfate | Eczema More | Approved |
Prednisolone valerate acetate ( GR ) | Eczema More | Approved |
Betamethasone Dipropionate ( GR ) | Eczema More | Approved |